Related Experiment Video
Updated: Dec 6, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Cancer risks associated with the germline MITF(E318K) variant
Samantha M Guhan1, Mykyta Artomov2, Shelley McCormick3
1Wellman Center for Photomedicine at Massachusetts General Hospital, Edwards 211, 50 Blossom Street, Boston, MA, 02114, USA.
Abstract:
The MITF(E318K) variant confers moderate risk for cutaneous melanoma. While there are small studies suggesting that this risk is associated with other malignancies (e.g. renal cell carcinoma), little is known about the role of this variant in specifying risk for other cancers. In this study, we perform a systematic review and meta-analysis of the published data as a backdrop to a whole-exome sequence(WES)-based characterization of MITF(E318K) risk for various cancers in sporadic samples from the TCGA and several genetically-enriched patient cohorts. We found minimal evidence of MITF(E318K)'s contribution to non-melanoma cancer risk among individuals with low inherited risks of melanoma (OR 1.168; 95% CI 0.78-1.74; p = 0.454), suggesting that earlier reports of an association between this variant and other malignancies may be related to shared environmental or polygenic risk factors rather than MITF(E318K). Interestingly, an association was observed with uterine carcinosarcoma, (OR 9.24; 95% CI 2.08-37.17; p = 0.024), which was not previously described. While more research needs to be completed, this study will help update cancer screening recommendations for patients with the MITF(E318K) variant.
Insights
The MITF(E318K) variant primarily increases cutaneous melanoma risk. This study found minimal evidence for other cancer risks, except for a novel association with uterine carcinosarcoma.
Area of Science:
- Genetics
- Oncology
- Genomic Medicine
Background:
- The MITF(E318K) variant is a known risk factor for cutaneous melanoma.
- Limited data exists on its association with other cancer types.
- Previous studies suggested links to malignancies like renal cell carcinoma, but lacked comprehensive analysis.
Purpose of the Study:
- To systematically review and meta-analyze existing data on MITF(E318K) and cancer risk.
- To characterize the risk of MITF(E318K) for various cancers using whole-exome sequencing data.
- To clarify the role of MITF(E318K) in non-melanoma cancer predisposition.
Main Methods:
- Systematic review and meta-analysis of published literature.
- Whole-exome sequencing (WES) analysis of sporadic cancer samples from The Cancer Genome Atlas (TCGA).
- Analysis of genetically-enriched patient cohorts.
Main Results:
- Minimal evidence supports MITF(E318K) contribution to non-melanoma cancer risk in low-risk individuals (OR 1.168, p=0.454).
- An unexpected significant association was found between MITF(E318K) and uterine carcinosarcoma (OR 9.24, p=0.024).
- Findings suggest prior associations with other malignancies may stem from shared environmental or polygenic factors.
Conclusions:
- The MITF(E318K) variant's primary role is in melanoma risk, with limited evidence for other cancers.
- A novel association with uterine carcinosarcoma warrants further investigation.
- Results may inform updated cancer screening guidelines for individuals carrying the MITF(E318K) variant.
Related Concept Videos
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Cancers Originate from Somatic Mutations in a Single Cell
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Induced Pluripotent Stem Cells
Somatic...

